Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gastl

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Cancer Research|November 15, 1992
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cellsG Gastl, C L Finstad, A Guarini, et al.
Cancer Research|July 1, 1985
Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expressionG Gastl, C Marth, E Leiter, et al.
Blut|May 1, 1989
Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapyM A Fridrik, G Wahl, W Herbinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gammaW Aulitzky, G Gastl, W E Aulitzky, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Annals of Hematology|February 1, 1991
Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2W E Aulitzky, H Tilg, W Vogel, et al.
British Journal of Haematology|November 1, 1985
Recombinant alpha 2 interferon for induction and maintenance of remission in hairy cell leukaemiaG Gastl, W Aulitzky, R Margreiter, et al.
Clinical and Experimental Immunology|May 12, 2007
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantationJ Clausen, D Wolf, A L Petzer, et al.
British Journal of Cancer|September 25, 2008
High expression of TROP2 correlates with poor prognosis in pancreatic cancerD Fong, P Moser, C Krammel, et al.
Onkologie|June 1, 1985
Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemiaG Gastl, H Denz, C Abbrederis, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Cancer Research|November 15, 1992
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cellsG Gastl, C L Finstad, A Guarini, et al.
Cancer Research|July 1, 1985
Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expressionG Gastl, C Marth, E Leiter, et al.
Blut|May 1, 1989
Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapyM A Fridrik, G Wahl, W Herbinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gammaW Aulitzky, G Gastl, W E Aulitzky, et al.
Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.
Annals of Hematology|February 1, 1991
Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2W E Aulitzky, H Tilg, W Vogel, et al.
British Journal of Haematology|November 1, 1985
Recombinant alpha 2 interferon for induction and maintenance of remission in hairy cell leukaemiaG Gastl, W Aulitzky, R Margreiter, et al.
Clinical and Experimental Immunology|May 12, 2007
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantationJ Clausen, D Wolf, A L Petzer, et al.
British Journal of Cancer|September 25, 2008
High expression of TROP2 correlates with poor prognosis in pancreatic cancerD Fong, P Moser, C Krammel, et al.
Onkologie|June 1, 1985
Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemiaG Gastl, H Denz, C Abbrederis, et al.
Pageof 14